Initial 3-Weeks’ Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial

BACKGROUND: Nondisabling cerebrovascular events represent the largest group of cerebrovascular disease with a high risk of recurrent stroke. A recent trial demonstrated that dual-antiplatelet therapy (clopidogrel and aspirin), compared with aspirin monotherapy, reduced the risk of recurrent stroke a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fang, Lei, Hui, Jiang, Wenrui, Jiang, Wen, Han, Junliang, Zhao, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210645/
https://www.ncbi.nlm.nih.gov/pubmed/25200142
http://dx.doi.org/10.1007/s40261-014-0228-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210645/
https://www.ncbi.nlm.nih.gov/pubmed/25200142
http://dx.doi.org/10.1007/s40261-014-0228-8

Ejemplares similares